Regencell Bioscience Holdings Ltd banner

Intrinsic Value

Is RGC undervalued or overvalued?

See the intrinsic value estimate for Regencell Bioscience Holdings Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

RGC Intrinsic Value
LOCKED
Unlock
Today vs. history

RGC looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with RGC’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor RGC
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price $7.27
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RGC

Fundamental Analysis

What Regencell Bioscience Does

Pharmaceuticals Health Care

Regencell Bioscience Holdings is a small bioscience company focused on traditional Chinese medicine, especially formulas aimed at children with neurocognitive conditions such as autism and ADHD. Instead of making broad drug pipelines, it centers on a narrow set of TCM-based products and treatment approaches built around its own research and formulas.

Headquarters
Hong Kong HK
Employees
10
IPO date
Jul 16, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Regencell Bioscience Holdings Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one RGC stock?

The intrinsic value for Regencell Bioscience Holdings Ltd (RGC) under the Base Case is hidden USD.

Is RGC stock undervalued or overvalued?

Compared with the current market price of 7.27 USD, the stock appears hidden.

Back to Top